Auristone
Latest round
- Seed
Last raised
- Mar 2025
Total raised
- $4.6M
Investors
- 4
About Auristone
Established in 2021 and based in Singapore, Auristone is a biotech company that focuses on epigenomic analysis. The company's scientific co-founders are Prof. Patrick Tan and Prof. Teh Bin Tean, experts in the fields of epigenomics and gastric cancer (GC), as well as genomics, translational research and drug discovery, respectively. The company is dedicated to clinical and academic epigenomic research. The company's self-developed sequencing NGS (Next-generation sequencing) test platform EPI-Call, which provides epigenomic information about the tumor microenvironment and predicts patient response to immunotherapy.
Who invested in Auristone
4 investors across 2 rounds
See all investors in Auristone
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Auristone
Who invested in Auristone?
Auristone has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Auristone raised?
Auristone has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Auristone last raise money?
Auristone's most recent round on record is a Seed, in Mar 2025.
What does Auristone do?
Established in 2021 and based in Singapore, Auristone is a biotech company that focuses on epigenomic analysis.
Where is Auristone headquartered?
Auristone is headquartered in Singapore.
Which VCs invest in companies like Auristone?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Auristone's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Auristone? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.